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Introduction
Photoactivation of a visual pigment molecule in vertebrate rod 
and cone photoreceptors rapidly triggers a light response and con-
comitantly renders the activated pigment unable to detect a sub-
sequent photon of light. Regeneration of the visual pigment back 
to the ground state requires recycling of its chromophore from 
the “bleached” all-trans retinal to the light-sensitive 11-cis retinal. 
This process, known as the visual cycle, requires export of the all-
trans chromophore out of the photoreceptors and its conversion to 
the 11-cis form in retinal pigment epithelial (RPE) cells (for both 
rods and cones) or in retinal Müller glia (for cones only). The 11-cis 
chromophore is then imported back into photoreceptors, where 
it combines with a molecule of free opsin to regenerate the visual 
pigment (1, 2). The cone-specific visual cycle (3) has been sug-
gested to enable cones, but not rods, to quickly recover from bright 
light exposure and to function over a wide range of light intensities 
(4–6). While an active area of research (7, 8), to date, none of the 
putative molecular components in this pathway have been shown 
to actually affect mammalian cone function, casting doubt on the 
significance of this pathway.
Cellular retinaldehyde–binding protein (CRALBP) is a retin-
oid-binding protein expressed in RPE and Müller glia and believed 
to be involved in the retinal visual cycle (1). CRALBP is a 36-kDa 
water-soluble protein with 2 conformational states facilitating 
the intracellular transport of hydrophobic 11-cis retinoids (9). In 
zebrafish, 2 distinct orthologs, cralbp a and cralbp b, are expressed 
in RPE and Müller cells, respectively (10, 11). Notably, knockdown 
of either of the 2 isoforms leads to decreased cone-driven elect-
roretinographic (ERG) responses (10), suggesting a role of Müller 
cell–expressed CRALBP in zebrafish cone function (see also ref. 
12). In mammals, CRALBP is encoded by a single gene, Rlbp1, 
expressed in both RPE and Müller cells. Mutations in human 
RLBP1 cause several autosomal recessive retinal diseases, such 
as autosomal recessive retinitis pigmentosa (13), Bothnia dystro-
phy (14–16), retinitis punctata albescens (17), fundus albipuncta-
tus (18, 19), and Newfoundland rod-cone dystrophy (20). These 
visual disorders are characterized by early-onset night blindness 
and may be followed by functional defects in the macular region 
(21). CRALBP is required for the proper function of the RPE visual 
cycle and for the timely recovery of mammalian rod and cone 
ERG responses (22). However, the role of Müller cell–expressed 
CRALBP in the mammalian retinal visual cycle is unknown. It is 
also not clear whether CRALBP in RPE, Müller cells, or both is 
required for the normal function of mammalian cones. Here, we 
used behavioral and electrophysiological assays in Rlbp1–/– mice to 
examine the overall effect of CRALBP deletion on M-cone func-
tion. We also used molecular tools to explore the mechanism by 
which the lack of CRALBP causes cone function deterioration. 
We then used adeno-associated virus–mediated (AAV-mediated) 
gene transfer to selectively restore CRALBP in RPE or Müller cells 
and examine the distinct roles of the 2 visual cycles in supporting 
mammalian M-cone function.
Results
The deletion of CRALBP suppresses mammalian cone visual func-
tion. In addition to causing well-documented rod-driven scotopic 
visual disorders (15, 17), mutations in CRALBP also disrupt cone-
driven photopic vision in humans (13, 16, 20). It is believed that 
Mutations in the cellular retinaldehyde–binding protein (CRALBP, encoded by RLBP1) can lead to severe cone photoreceptor–
mediated vision loss in patients. It is not known how CRALBP supports cone function or how altered CRALBP leads to 
cone dysfunction. Here, we determined that deletion of Rlbp1 in mice impairs the retinal visual cycle. Mice lacking CRALBP 
exhibited M-opsin mislocalization, M-cone loss, and impaired cone-driven visual behavior and light responses. Additionally, 
M-cone dark adaptation was largely suppressed in CRALBP-deficient animals. While rearing CRALBP-deficient mice in the 
dark prevented the deterioration of cone function, it did not rescue cone dark adaptation. Adeno-associated virus–mediated 
restoration of CRALBP expression specifically in Müller cells, but not retinal pigment epithelial (RPE) cells, rescued the 
retinal visual cycle and M-cone sensitivity in knockout mice. Our results identify Müller cell CRALBP as a key component 
of the retinal visual cycle and demonstrate that this pathway is important for maintaining normal cone–driven vision and 
accelerating cone dark adaptation.
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20-fold decrease in photopic sensitivity, as measured by the corre-
sponding increase in I1/2 (the flash intensity required to achieve a 
half-maximal response) of the Rlbp1–/– cone b-wave responses (Fig-
ure 1B). Surprisingly, light sensitivity in the absence of CRALBP 
was diminished to such an extent that even the brightest light stim-
ulus of the ERG system (697 cd × s/m2, Xenon flash) could not gen-
erate a saturated photopic b-wave response (Figure 1B, red circles). 
In contrast, light sensitivity in Rlbp1+/– mice was comparable to that 
in control mice (Figure 1B, blue triangles, inset).
In the course of these recordings, we noticed that the older 
Rlbp1–/– mice had smaller cone b-wave amplitudes than did the 
young adult mice. We compared the ERG b-wave responses from 
6- to 7-week-old and 13- to 16-week-old mice to examine the 
long-term effect of CRALBP knockout on mouse photopic vision. 
In control animals, cone b-wave amplitude showed an approxi-
mately 10% (NS) reduction with age (Figure 1C). In contrast, the 
cone b-wave amplitude of Rlbp1–/– mice decreased by nearly 50% 
(P < 0.001) over the same 2-month period (Figure 1D). The light 
sensitivity, as estimated from the I1/2 of the respective normalized 
intensity-response curves, remained unchanged for both groups 
within the 2 months of aging (Figure 1, C and D, insets). Thus, the 
deletion of CRALBP caused a dramatic and progressive reduction 
in cone-driven visual performance.
The deletion of CRALBP desensitizes mammalian cones and lowers 
their phototransduction amplification. The reduced photopic b-wave 
amplitude and sensitivity of CRALBP-deficient mice could be 
caused by a deficit either in cone phototransduction or in cone-to-
bipolar cell synaptic transmission. To distinguish between the 2 
possibilities, we determined whether cone phototransduction was 
affected directly by the deletion of CRALBP by performing ex vivo 
the pathophysiology for both rods and cones is based on inefficient 
chromophore recycling (13, 14). However, the exact mechanisms 
of cone dysfunction in CRALBP-related diseases and the relative 
contributions of the RPE visual cycle and the retinal visual cycle 
to cone dark adaptation are unknown. To address these questions, 
we first examined how the deletion of CRALBP affects the cone-
driven photopic visual performance of CRALBP-knockout mice by 
optomotor response behavioral tests. All functional experiments 
were performed with knockout mice lacking the rod transducin α 
subunit (Gnat1–/–). This facilitated the isolation of cone function 
by ablating rod photoresponses while preserving normal retina 
morphology and cone function (6, 23). The experiments were per-
formed with LCD monitor white light, which would be expected to 
selectively activate mouse M-cones (peak absorption at 508 nm) 
but not S-cones (peak absorption at 360 nm) (24). We found that 
the background light intensity required to achieve half-maximal 
cone-driven contrast sensitivity in 6-week-old Rlbp1–/– mice was 
approximately 10-fold higher than that required for controls (–0.4 
and –1.3 log cd × s/m2, respectively). Thus, the absence of CRALBP 
caused a substantial desensitization of cone-driven vision.
We then asked whether the vision loss observed at a behav-
ioral level was caused by the deterioration of cone function in the 
absence of CRALBP. We conducted in vivo ERG recordings to 
examine the dark-adapted cone b-wave responses of 6- to 13-week-
old Rlbp1–/– mice. We used 530-nm LED flashes to selectively excite 
M-cones (24) up to the system’s 25 cd × s/m2  intensity limit and 
Xenon flash for higher intensities. We observed a significant 40% 
(P < 10–4) decrease in the maximal M-cone b-wave amplitude in 
Rlbp1–/– mice compared with that in both Rlbp1+/+ (control) and 
Rlbp1+/– mice (Figure 1, A and B). In addition, we found a dramatic 
Figure 1. Deletion of CRALBP reduces photopic in vivo ERG–response amplitude and sensitivity. (A) Representative in vivo cone ERG responses from 
control (black traces), Rlbp1–/– (red traces), and Rlbp1+/– (blue traces) mice. Test flash intensities increased from 2.27 × 10–2 cd × s/m2 (bottom traces) to 697 
cd × s/m2 (top traces) in steps of approximately 0.5 log units. (B) Ensemble-averaged cone b-wave intensity-response curves for control (n = 10), Rlbp1–/–  
(n = 12), and Rlbp1+/– (n = 10) mice. (C) Cone b-wave intensity-response curves for control mice aged 6–7 weeks (black squares, n = 8) and 13–16 weeks (white 
squares, n = 10). (D) Cone b-wave intensity-response curves for Rlbp1–/– mice aged 6–7 weeks (red circles, n = 6) and 13–16 weeks (white circles, n = 6). Insets 
in B–D show the corresponding normalized (r/rmax) intensity-response curves. Results represent the mean ± SEM.
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cone dark adaptation. Using in vivo ERG recordings, we examined 
the cone b-wave sensitivity recovery of control and Rlbp1–/– mice 
following exposure to a brief bright-green light estimated to pho-
toactivate (bleach) 90% of the M-cone visual pigment (see Meth-
ods for details). As expected, cone b-wave sensitivity in the con-
trol mice underwent robust recovery following the bleaching and 
returned within 50 minutes to an estimated 50% of the pre-bleach-
ing level (Figure 3A, black squares). An incomplete photoreceptor 
dark adaptation after bleaching, as detected in ERG recordings of 
WT mice, is not unusual (6) and is most likely caused by the general 
anesthetics (25). In striking contrast to the ERG response recovery 
in control mice, M-cones in Rlbp1–/– mice recovered only a slight 
fraction of their sensitivity following an identical bleaching (Figure 
3A, red circles). Thus, cone dark adaptation in vivo, driven through 
the combined action of the RPE and Müller cell visual cycles, was 
severely compromised by the deletion of CRALBP. Notably, the 
effect of CRALBP deletion on the recovery of cone sensitivity was 
more pronounced than the previously reported delay in recovery of 
cone b-wave–response amplitudes (22).
Next, to determine the specific effect of CRALBP deletion on 
the Müller cell visual cycle, we performed cone dark-adaptation 
experiments in retina dissected free of RPE, in which cone pig-
ment regeneration can be driven only by the retinal visual cycle. 
After an initial greater than 100-fold desensitization caused by 
the bleaching, within seconds, cones in both control and Rlbp1–/– 
retinae showed a rapid initial increase in sensitivity (Figure 3B). 
This partial recovery, which was most likely due to inactivation 
of the phototransduction cascade following the bleaching, was 
comparable in the 2 mouse strains. However, the Rlbp1–/– cone 
sensitivity failed to recover further during the 12 minutes of post-
bleach recordings, while control cones recovered to within 5-fold 
of their pre-bleaching level (Figure 3B). We conclude that dele-
tion of CRALBP has a dramatic effect on the ability of the reti-
nal visual cycle to promote mouse cone dark adaptation. Taken 
together, these results demonstrate that CRALBP plays a role 
in both the RPE and retinal visual cycles and that its deletion 
severely impairs the ability of both pathways to promote mamma-
lian cone dark adaptation.
Dark rearing of CRALBP-deficient mice restores cone function 
but not cone dark adaptation. It is believed that the role of CRALBP 
in both the RPE and retinal visual cycles is to accelerate the pro-
duction of 11-cis retinoid (1). We hypothesized that in the absence 
of CRALBP, both visual cycles would still remain functional but 
would fail to provide sufficient chromophore for sustaining normal 
recordings from isolated retina. This technique allowed us to phar-
macologically block synaptic transmission (see Methods) and iso-
late the cone (a-wave) response. We used a 505-nm LED flash light 
to stimulate the M-cones in these recordings. Similar to the in vivo 
ERG b-wave results above, the ex vivo transretinal responses from 
Rlbp1–/– cones were smaller than those from control cones, with a 
greater than 50% (P < 0.05) decrease in maximal amplitude (Fig-
ure 2, A and B). Indicative of their reduced sensitivity, the responses 
of Rlbp1–/– M-cones could not be saturated, even at the maximal 
possible light intensity of our system (Figure 2B). The analysis of 
their corresponding intensity-response functions showed a 20-fold 
lower sensitivity (higher I1/2) compared with that in control cones 
(Figure 2B, inset). The absence of CRALBP also resulted in a some-
what accelerated cone response inactivation (Figure 2C). In addi-
tion, consistent with their reduced light sensitivity, CRALBP-defi-
cient cones had a 9-fold smaller phototransduction amplification 
compared with that in control cones (Figure 2D), revealed by the 
corresponding scaling factor required to match the rising slopes of 
the fractional dim flash responses to 103 photons/μm2 for control 
cones and 1,387 photons/μm2 for Rlbp1–/– cones. Taken together, 
these results demonstrate that deletion of CRALBP in mice leads 
to severe desensitization and altered cone phototransduction in 
dark-adapted M-cones, which in turn produces a desensitized cone 
b-wave and suppressed cone-mediated vision.
Deletion of CRALBP severely impairs mammalian cone dark adap-
tation. We next sought to determine the effect of CRALBP deletion 
on RPE and retina visual cycles in the context of cone dark adapta-
tion. First, we determined the overall effect of CRALBP deletion on 
Figure 2. Deletion of CRALBP reduces transretinal cone-response ampli-
tude and sensitivity. (A) Representative transretinal cone responses from 
control (left panel) and Rlbp1–/– (right panel) retinae. Test flash intensities 
increased from 23 photons/μm2 to 1.40 × 106 photons/μm2 in steps of 
0.5 log units. For both panels, the flash intensity producing the response 
shown in red was 1.39 × 104 photons/μm2. (B) Ensemble-averaged absolute 
and normalized (inset) cone intensity-response curves for control  
(n = 13) and Rlbp1–/– (n = 13) retinae. (C) Ensemble-averaged normalized 
cone dim flash responses from control (n = 12) and Rlbp1–/– (n = 13) retinae. 
(D) Ensemble-averaged dim flash responses, r, from control (n = 13) and 
Rlbp1–/– (n = 11) cones normalized to the maximal response, rmax, and to 
flash intensity and with matched rising slopes to determine the change in 
phototransduction amplification. Results are shown as the mean ± SEM.
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in Rlbp1–/– cones in detectable amounts and therefore is not the 
cause for the reduced sensitivity and response amplitude of cones 
in CRALBP-deficient mice.
We next examined whether the suppressed M-cone function 
in CRALBP-knockout mice is caused by a long-term chromophore 
deficiency. We raised Rlbp1–/– newborn mice in near-complete 
darkness to substantially slow down the consumption of chro-
mophore in their eyes and lower the demand for recycled chro-
mophore by the cones. It was recently shown that raising mice 
in complete darkness leads to an eventual decline in cone-to-
bipolar cell synaptic transmission (28). However, the occasional 
cone function in 12-hour light/12-hour dark cyclic conditions. To 
test this idea, we first attempted to restore cone function in Rlbp1–/– 
mice by supplying them with exogenous chromophore in order to 
regenerate any free cone opsin into visual pigment. However, the 
application of either 9-cis retinal in vivo (Figure 4A) or 11-cis reti-
nal ex vivo (Figure 4B) failed to rescue M-cone sensitivity. In con-
trast, treatment of chromophore-deficient Rpe65–/– retinae with 
exogenous 11-cis retinal ex vivo and application of 9-cis retinal to 
Rpe65–/– mice in vivo resulted in a robust increase in rod sensitivity 
and maximal response (data not shown), as previously reported 
(26, 27). These results demonstrate that free opsin is not present 
Figure 3. The deletion of CRALBP 
suppresses cone dark adaptation. (A) 
Normalized cone b-wave sensitivity (b-wave 
Sf /b-wave Sf
DA) from in vivo ERG recordings 
during dark adaptation following 90% pig-
ment bleaching at t = 0 for control (n = 10) 
and Rlbp1–/– (n = 10) mice. (B) Cone sensitiv-
ity, Sf, normalized to its dark-adapted value, 
Sf
DA, from transretinal recordings during dark 
adaptation following 90% pigment bleach-
ing at t = 0 for control (n = 9) and Rlbp1–/–  
(n = 10) isolated retinae. Results represent 
the mean ± SEM.
Figure 4. Dark rearing, but not acute treatment with exogenous chromophore, rescues CRALBP-deficient cone sensitivity. (A) Normalized in vivo ERG 
cone b-wave intensity-response curves for untreated control (replotted from Figure 2B inset) and 9-cis retinal–treated (n = 6) Rlbp1–/– mice. (B) Normal-
ized transretinal cone intensity-response curves for control (black, n = 6) and Rlbp1–/– (red, n = 6) retinae in control solution (filled symbols; replotted 
from Figure 3B inset) and after treatment with exogenous 11-cis retinal (open symbols, n = 6). 9cRal, 9-cis retinal; 11cRal, 11-cis retinal. (C) Cone b-wave 
intensity-response curves from in vivo ERG recordings of control mice raised in cyclic light (black squares, n = 14) or in darkness (white squares, n = 10). (D) 
Cone b-wave intensity-response curves from in vivo ERG recordings of control (black squares; replotted from Figure 1B) and Rlbp1–/– mice raised in cyclic 
light (red filled circles; replotted from Figure 1B) and Rlbp1–/– mice raised in darkness (open red circles, n = 10). Insets in C and D show the corresponding 
normalized intensity-response curves. (E) Normalized cone b-wave sensitivity (b-wave Sf / b-wave SfDA) from in vivo ERG recordings during dark adaptation 
following 90% pigment bleaching at t = 0 for control (black squares) and Rlbp1–/– mice raised in cyclic light (filled red circles; replotted from Figure 4A) and 
for Rlbp1–/– mice raised in darkness (open red circles, n = 10). Results represent the mean ± SEM.
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phore enough to preserve cone function. However, dark rearing 
alone does not address the underlying deficit in the RPE and/or 
retinal visual cycles.
Deletion of CRALBP induces M-opsin mislocalization and loss 
of M-cones. What is the molecular mechanism underlying the 
functional deterioration in CRALBP-deficient cones? Based on 
the physiological results above, we hypothesized that CRALBP 
was required for proper localization of opsin protein. To test this 
hypothesis, we stained frozen sections from Rlbp1–/– and control 
retinae with cone opsin antibodies. Whereas M-opsin was local-
ized to the cone outer segment of the control retinae as expected, 
we observed striking mislocalization of M-opsin to the cone cell 
bodies, axons, and pedicles of young (6-week-old) and old (4- 
to 6-month-old) Rlbp1–/– mice raised conventionally in cyclic 
light-dark conditions. Intriguingly, dark rearing of Rlbp1–/– mice 
brief exposure to room light during routine animal care was 
sufficient to maintain normal cone function in our control mice 
and resulted in only a slight increase in the maximal amplitude 
of their in vivo ERG b-wave response (Figure 4C). Importantly, 
the photopic b-wave sensitivity of control mice, as measured from 
their normalized intensity-response curve, was unchanged by the 
dark rearing (Figure 4C, inset). In contrast, raising Rlbp1–/– mice 
in darkness not only restored cone b-wave maximal response 
(Figure 4D), but also boosted cone sensitivity levels to those of 
control cones (Figure 4D, inset). However, a subsequent expo-
sure to bleaching light unmasked the deficiency in cone pigment 
regeneration, as the dark adaptation in CRALBP-deficient mice 
was identical for animals raised in darkness and in cyclic light 
(Figure 4E). Together, these results demonstrate that the dark 
rearing of Rlbp1–/– mice slows down the consumption of chromo-
Figure 5. Deletion of CRALBP affects the localization of M-opsin and number of cones expressing M-opsin. Antibody staining of retinal frozen sections 
from Rlbp1–/– and control mice for (A) M-opsin and (B) S-opsin. Representative images are shown. At least 3 retinae per condition were examined. Scale 
bars: 25 μm. COS, cone outer segment; ONL, outer nuclear layer; OPL, outer plexiform layer. For clarity, the DAPI channel is not shown. (C) Quantification 
of whole-mount M-opsin antibody staining (n = 4 retinae per condition). *P < 0.05, **P < 0.01 by unpaired 2-tailed Student’s t test. (D) Quantification of 
whole-mount S-opsin antibody staining (n = 3 retinae per condition). D, dorsal; T, temporal; N, nasal; V, ventral. Young, 6- to 7-week-old mice; Old, 3- to 
6-month-old mice. Results represent the mean ± SEM.
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appeared to ameliorate M-opsin mislocalization to some extent 
(Figure 5A), consistent with the physiology results above. In con-
trast to M-opsin, S-opsin was appropriately localized to the cone 
outer segments in the retinae of both Rlbp1–/– and control mice (Fig-
ure 5B). We also wondered whether the M-opsin mislocalization 
in Rlbp1–/– retinae was correlated with M-cone numbers. Quanti-
fication of whole-mount antibody staining revealed a lower den-
sity of M-opsin–expressing cones in the dorsal retinae of Rlbp1–/– 
mice compared with dorsal retinae in age-matched controls (Fig-
ure 5C), whereas the density of S-opsin–expressing cones was not 
affected (Figure 5D). Thus, the deletion of CRALBP resulted in 
both mislocalization of M-opsin and M-cone loss. However, over-
all, the cone density in Rlbp1–/– retinae did not change markedly 
with age, suggesting that the observed age-dependent decline in 
cone function was caused by progressive deterioration in the light 
responses of individual M-cones.
The retinal visual cycle is essential for cone function. In the above 
results, we demonstrated that CRALBP was crucial for maintain-
ing normal M-cone function in a cyclic light environment and for 
proper cone dark adaptation. However, because in these experi-
ments CRALBP was absent in both RPE and Müller cells, we were 
not able to determine the relative contribution of each visual cycle 
to maintaining normal cone function. To address this question, 
we used 2 separate AAV vectors to express CRALBP specifically 
in either RPE or Müller cells of adult Rlbp1–/– mice (see Methods 
for details). First, we verified that CRALBP was delivered via intra-
vitreal AAV injection to the RPE (via the RPE-specific AAV con-
struct 7m8-scVMD2-RLBP1) or to the Müller cells (via the Müller 
cell-specific AAV construct shH10-scCAG-RLBP1) in Rlbp1–/– reti-
nae. As previously shown (22), antibody staining revealed robust 
CRALBP expression in the RPE and Müller cells of WT mice 
(Figure 6A) and its complete absence in Rlbp1–/– eyes (Figure 6B). 
Notably, immunohistochemistry revealed expression of CRALBP 
specifically in the targeted cell type for both AAV constructs (Fig-
ure 6, C and D). Moreover, the extent of intravitreal AAV infec-
tion appeared to be widespread, as demonstrated by the CRALBP 
expression in the targeted cell type along the length of the retina 
(Figure 6, E and F).
We then examined how the rescue of each visual cycle affected 
the dark-adapted function of M-cones as well as their ability to 
recover light sensitivity rapidly following a bleaching. The trans-
retinal recordings revealed that dark-adapted cone sensitivity in 
Müller cell CRALBP–expressing Rlbp1–/– mice was improved by 
approximately 10-fold (Figure 7A) and that amplification of cone 
phototransduction was enhanced by 5.8-fold compared with con-
trols (Figure 7B). In contrast, dark-adapted cone responses from 
RPE cell CRALBP–expressing Rlbp1–/– mice were indistinguishable 
from those of their AAV-GFP–injected littermates (Figure 7, A and 
B). This result demonstrates that expression of CRALBP in Müller 
cells is required for the normal function of dark-adapted M-cones. 
The dim flash–response kinetics, cone maximal response, and 
cone b-wave maximal response were not affected by either RPE 
or Müller cell expression of CRALBP (data not shown), indicating 
an incomplete rescue of cone function. We also note that AAV-
mediated CRALBP delivery to either RPE or Müller cells failed 
to correct the M-opsin mislocalization defect (data not shown). 
Notably, in vivo cone dark adaptation was markedly improved 
by the AAV-mediated CRALBP rescue of either visual cycle with 
indistinguishable time courses (Figure 7C). In contrast, only the 
expression of CRALBP in Müller cells resulted in the rescue of 
cone dark adaptation in the isolated RPE-free retina, whereas 
expression of CRALBP in RPE had no effect on cone dark adap-
tation under these conditions (Figure 7D). Together, these results 
demonstrate the role of the retinal visual cycle in supporting mam-
malian M-cone function and indicate that CRALBP in Müller cells 
plays a key role in this pathway.
Figure 6. AAV-mediated delivery of CRALBP to Müller cells or RPE cells. Antibody staining shows expression pattern of CRALBP in (A) control retina, (B) 
Rlbp1–/– retina, (C) Müller cells of Rlbp1–/– retina after intravitreal injection with an AAV construct targeted for Müller cells shH10-scCAG-RLBP1, and (D) RPE 
of Rlbp1–/– retina after intravitreal injection with an AAV construct targeted for RPE 7m8-scVMD2-RLBP1. Scale bars: 50 μm. INL, inner nuclear layer; GCL, 
ganglion cell layer. Widespread infection across the retina was achieved for both constructs, as seen in tiled images for (E) shH10-scCAG-RLBP1 and (F) 
7m8-scVMD2-RLBP1. Red channel, anti-CRALBP; blue channel, DAPI. Scale bar: 200 μm.
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Deletion of CRALBP affects the pupillary light reflex. Besides 
rods and cones, another cell type in the retina that requires chro-
mophore for its function is the intrinsically photosensitive retinal 
ganglion cell (ipRGC) (29). CRALBP in Müller cells was recently 
proposed to facilitate the supply of 11-cis retinal to ipRGCs 
(30). We investigated this possibility by evaluating the effect of 
CRALBP deletion on light-driven pupil constriction. Rods in both 
control and Rlbp1–/– mice do not respond to light due to the absence 
of GNAT1, and their pupillary light reflex is therefore mediated by 
the 2 remaining light-sensitive cell types in the retina: cones and 
ipRGCs (31). In melanopsin-knockout animals that lack melanop-
sin phototransduction but maintain normal cone function, there 
is a clear reduction in the magnitude of the pupillary light reflex, 
but only at high light intensities (32). To determine whether mela-
nopsin phototransduction is affected in Rlbp1–/– mice, we exposed 
1 eye to light and measured pupil constriction in the contralateral 
eye (Figure 8A). This enabled us to evaluate the overall sensitivity 
of the pupillary light reflex. Two-way ANOVA analysis showed an 
overall significant difference (P < 0.001) between the pupil con-
striction intensity-response curves of control and Rlbp1–/– mice. 
Further 1-way ANOVA statistical analysis followed by Bonferroni’s 
correction on the P values at each intensity revealed a significantly 
higher (P < 0.05) threshold for pupil constriction in Rlbp1–/– mice 
compared with that in controls (Figure 8B). The light intensity 
required to reach 50% effective constriction (EC50) was also 
slightly higher in CRALBP-deficient mice compared with that in 
controls, but the difference was not statistically significant (Figure 
8C). The maximal pupil constriction in bright light of Rlbp1–/– mice 
was comparable to that of controls, suggesting that the function 
of ipRGCs is largely unaffected by the deletion of CRALBP (32). 
In contrast, the maximal pupillary light reflex of Rpe65–/– mice, 
in which all photoreceptor function is severely suppressed due to 
a lack of chromophore (33), was dramatically reduced (Figure 8, 
A and B). This analysis suggests that the pupillary light reflex is 
overall different in Rlbp1–/– mice, with the difference restricted to 
relatively dim light levels, in which the pupil response is primar-
ily driven by cone signals. The response at higher light intensities, 
which is dominated by the ipRGC signals, was not affected by the 
deletion of CRALBP. Together, these results indicate that CRALBP 
is not required for the delivery of chromophore to ipRGCs or for 
the regeneration of melanopsin and that the decreased sensitivity 
of the pupillary light reflex in Rlbp1–/– mice is most likely caused by 
suppressed cone function. However, a conclusive determination 
of this issue would require the generation of triple-knockout ani-
mals that lack both rod and cone phototransduction pathways in 
addition to a lack of the Rlbp1 gene.
Discussion
Molecular evidence for the function of a mammalian retinal visual 
cycle. The idea of a second, cone-specific visual cycle was first 
put forth in the 1970s (34) and has been gaining acceptance and 
experimental support in recent years (3, 4, 35). This pathway 
was proposed to involve the conversion of spent all-trans retinol, 
released from cones, back into 11-cis retinol in the retinal Müller 
cells (3). Indeed, it was shown recently that the retina promotes 
pigment regeneration and dark adaptation in cones independently 
of the RPE, and that pharmacological ablation of Müller cells 
blocks this process (5). Recent biochemical studies have identified 
putative retinoid isomerase (7) and ester synthase activities (8) in 
Müller cells consistent with a retinal visual cycle. However, the 
molecular mechanism involved in the trafficking and recycling of 
chromophore still remains largely unknown, and skepticism still 
remains, partly due to the lack of experimental evidence for the 
involvement of any of the putative molecular players in this path-
Figure 7. AAV-driven expression of CRALBP in 
Müller cells rescues the sensitivity and dark adapta-
tion of CRALBP-deficient cones. (A) Ensemble-aver-
aged transretinal cone intensity-response curves for 
Rlbp1–/– mice injected with AAV driving expression of 
GFP in RPE or Müller cells (black squares, n = 4),  
CRALBP in Müller cells (red circles, n = 5), and 
CRALBP in RPE cells (green diamonds, n = 3). (B) 
Transretinal dim flash responses of Rlbp1–/– mice 
showing the relative amplification for AAV-driven 
control GFP (black, n = 4), Müller cell–specific 
CRALBP (red, n = 5), and RPE-specific CRALBP 
(green, n = 3) expression. (C) In vivo ERG recordings 
of cone b-wave dark adaptation (b-wave Sf/b-wave 
Sf
DA) after a 90% bleaching in Rlbp1–/– mice with AAV-
driven expression of control GFP (black, n = 11), Müller 
cell–specific CRALBP (red, n = 12), and RPE-specific 
CRALBP (green, n = 8). (D) Transretinal recordings of 
cone dark adaptation (Sf/Sf
DA) after a 90% bleaching 
of Rlbp1–/– retinae with AAV-driven expression of con-
trol GFP (black, n = 4), Müller cell–specific CRALBP 
(red, n = 5), and RPE-specific CRALBP (green, n = 3). 
Results represent the mean ± SEM.
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(Figures 1 and 2). Notably, this sup-
pressed cone function can be rescued 
by raising the animals in darkness 
(Figure 4). This result indicates that 
unlike the other widely studied chro-
mophore-binding protein IRBP (39, 
40), CRALBP is not required for the 
normal development and survival of 
cones. Instead, the preservation of 
normal cone function in dark-reared 
Rlbp1–/– mice suggests that the cone 
phenotype is caused by inadequate 
chromophore supply. One possibility 
is that the delayed recycling of chro-
mophore in the absence of CRALBP 
leads to chronic chromophore defi-
ciency, so that even after overnight 
dark adaptation of these mice, the 
pigment content of their cones is still 
not fully restored. However, consid-
ering that CRALBP-deficient rod responses are normal after 18 
hours of dark adaptation (22), it is unlikely that only cones would 
be affected by such incomplete dark adaptation. Indeed, our 
observation that application of exogenous chromophore failed to 
rescue cone function (Figure 4) rules out this possibility.
An alternative hypothesis is that the chronic deficiency of chro-
mophore affects cone opsin levels. Evidence for this notion comes 
from studies of a key enzyme in the RPE visual cycle, RPE65. In 
contrast to the slowed-down RPE visual cycle in Rlbp1–/– mice, 
Rpe65–/– mice lack this pathway completely and are unable to sup-
ply chromophore to their photoreceptors (41). This results in mis-
localization of cone opsin and very rapid degeneration of the cones 
(42, 43), both of which are attributed to chromophore deficiency 
(42, 44). Consistent with the role of chromophore in supporting 
cone opsin folding and expression, a recent study demonstrated 
that proper cone opsin expression requires sufficient chromophore 
supply to the endoplasmic reticulum (45). In addition, 11-cis ret-
inal in the inner segment of cones also appears to facilitate the 
transport of several phototransduction proteins to the cone outer 
segments (46). Thus, the deterioration of M-cone function that 
we observed in Rlbp1–/– mice is likely a direct result of the chromo-
phore deficiency caused by impairment of the retinal visual cycle. 
Notably, we found that S-cone opsin localization and expression 
were not affected in Rlbp1–/– mice (Figure 5, B and D), indicating 
that apo S-opsin might be more stable than its M-opsin counter-
part. It is intriguing in this context that mouse M-cones are more 
susceptible to age-dependent degeneration than are S-cones (47), 
suggesting that cone opsin stability might play a role in age-depen-
dent cone degeneration. Regardless of the mechanism affecting 
the loss of cone function in Rlbp1–/– mice, the rescued cone func-
tion in animals raised in darkness suggests that minimizing light 
exposure might be a simple and effective approach for protecting 
cones from degeneration and preventing photopic vision loss in 
patients with CRALBP-based visual disorders.
The contribution of 2 visual cycles to cone function. By selec-
tively rescuing either the RPE or Müller cell visual cycle using 
AAV-RLBP1 in Rlbp1–/– mice, we were able to identify the contribu-
way in actually controlling the function of cones. Here, we settle 
this question by demonstrating that the deletion of CRALBP in 
Müller cells prevents this pathway from promoting dark adapta-
tion in mouse cones. Our results also reveal a previously unappre-
ciated role of the retinal visual cycle in the long-term maintenance 
of normal mammalian cone function.
The role of CRALBP in the retinal visual cycle. We found that 
deletion of CRALBP in mice resulted in a dramatic suppression 
of cone dark adaptation both in vivo, when driven by the com-
bined action of the RPE and retinal visual cycles (Figure 3A), 
and ex vivo, when driven only by the retinal visual cycle (Figure 
3B). Therefore, suppression of the RPE visual cycle by deletion of 
CRALBP not only affects the rods, as previously shown by Saari et 
al. (22), but also compromises the ability of the RPE to drive the 
dark adaptation of cones. More important, our results also clearly 
demonstrate that CRALBP in Müller cells plays a similar role in 
the retinal visual cycle to promote cone dark adaptation.
What is the mechanism of CRALBP function in the retinal 
visual cycle? The rescue of cone function in dark-reared Rlbp1–/– 
mice indicates that deletion of CRALBP does not block the func-
tion of the retinal visual cycle; rather, CRALBP likely regulates 
its efficiency or kinetics. In RPE, CRALBP interacts with the 
isomerohydrolase to carry 11-cis retinol and facilitate its oxidation 
to 11-cis retinal (36). A recent study suggests that in vitro CRALBP 
closely interacts with DES1, the proposed retinoid isomerase in 
Müller cells (7). Therefore, it is possible that CRALBP takes up 
11-cis retinol from DES1 and facilitates the reisomerization of 
chromophore by the retinal visual cycle. CRALBP also facilitates 
the release of chromophore from RPE cells and its subsequent 
uptake by photoreceptors (37, 38). Thus, a second possibility is 
that CRALBP plays a similar role in Müller cells and accelerates 
the flow of chromophore to cones.
The influence of chromophore deficiency on cone function. Rods 
in CRALBP-deficient mice have normal sensitivity and maximal 
response after overnight dark adaptation (22). In striking con-
trast, dark-adapted cones in CRALBP-deficient mice have signifi-
cantly reduced response amplitude and 20-fold lower sensitivity 
Figure 8. Deletion of CRALBP reduces the threshold of the pupillary light reflex. (A) Comparison of pupil 
size in darkness and in the light (~14 log photons/cm2/s) in control, Rlbp1–/–, and Rpe65–/– (Gnat1+/+) negative 
control mice. (B) Averaged intensity-response curves for control (n = 5), Rlbp1–/– (n = 5), and Rpe65–/– (n = 4) 
mice. A significant difference was observed at threshold (*P < 0.05) between Rlbp1–/– and control mice by 
2-way ANOVA followed by Bonferroni’s post test. Results represent the mean ± SEM. (C) Intensity required 
to reach EC50 in control and Rlbp1
–/– mice. P = 0.10, NS, by 2-tailed unpaired Student’s t test.
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Photopic vision measured from optomotor responses. The threshold 
of contrast sensitivity was measured with a commercially available 
OptoMotry System (CerebralMechanics) as previously described (6). 
The intensity of the background light of the system was controlled with 
a custom-made cylinder of neutral-density filter film, wrapped around 
the mouse stand. The contrast-sensitivity threshold at a 0.128 cycles/
degree grating spatial frequency was measured by an automated com-
puter program when mice failed to provide optomotor responses. The 
tests started from brightest (1.84 log cd × s/m2) to dimmest (–3.56 
log cd × s/m2) background light intensity. Intriguingly, we observed 
that 2 of the tested CRALBP-deficient Gnat1–/– mice (Rlbp1–/–) did not 
respond normally to the moving bar in the test and instead rotated 
their head in the direction opposite to the moving bar. Therefore, we 
excluded the results from these 2 mice from our analysis.
Electrophysiology. In vivo ERG recordings were performed 
with a commercial LKC system (LKC Technologies) as previously 
described (6). The dark-adapted animals were anesthetized with 
ketamine (100 mg/kg) and xylazine (20 mg/kg), and their pupils 
were dilated with atropine sulfate eye drops. A mouse was placed 
onto a 37°C heating pad, and electrodes were connected to its cor-
nea to amplify electrical signals generated by the retina. A reference 
electrode was connected to beneath the skin at the scalp between 
the eyes. The animal was allowed to stabilize in darkness for 15 min-
utes before the recordings were started. Test flashes of increasing 
intensity (530-nm LED up to a 25 cd × s/m2 limit and white Xenon 
flash for higher intensities) were delivered by the Ganzfeld sphere, 
and the ERG signals were recorded to obtain the intensity-response 
curves. To test the dark-adaptation kinetics, bright-green LED light 
(520 nm) was used to bleach an estimated 90% of the photopig-
ments in 30 seconds. Then the cone sensitivity was recorded at pre-
set time intervals until 52 minutes after photobleaching. The cone 
b-wave flash sensitivity was normalized to the pre-bleaching value 
to determine the sensitivity recovery curve. For exogenous chromo-
phore application experiments, 300 μg 9-cis retinal was dissolved in 
200 μl NaCl/BSA solution (with 10% ethanol) and administered by 
i.p. injection. The treated animals were dark adapted overnight prior 
to in vivo ERG recordings.
Transretinal recordings were performed with isolated mouse ret-
ina as previously described (49, 50). The isolated retina was carefully 
mounted on a custom-made chamber for transretinal voltage record-
ings (51). The retina was perfused with Locke’s solution bubbled with 
O2 and CO2 and supplemented with 30 μM DL-AP4 to block synaptic 
transmission. After setting up the recording chamber, the retina was 
allowed to stabilize for 15 minutes before any recording was done. The 
responses of cones to 1-ms-long 505-nm LED-generated test flashes of 
various intensities were amplified and recorded on a desktop computer 
with pClamp 10 software (Molecular Dynamics). Dim flash analysis was 
performed with amplitude responses below 30% of the maximal ampli-
tude for each retina (52). For dark-adaptation tests, preprogrammed 
protocols were used to precisely monitor the fast recovery of cone 
sensitivity during the first 12 minutes following an estimated 90% 
photobleaching of the visual pigments. The cone sensitivity was nor-
malized to the pre-bleaching level to generate the sensitivity recovery 
curve. For exogenous chromophore application experiments, 300 μg 
11-cis retinal was dissolved in 4 ml 0.01% ethanol Locke’s solution, 
and an isolated retina was incubated with 0.5 to 1 ml of that solution 
for 1 hour in darkness. Cone responses from the treated retinae were 
tion of each visual cycle to supporting normal cone sensitivity and 
dark adaptation. Our finding that only rescue of the retinal visual 
cycle, but not the RPE visual cycle, restores normal sensitivity of 
dark-adapted Rlbp1–/– cones (Figure 7) reveals a previously unap-
preciated function of the retinal visual cycle and demonstrates 
that this pathway plays a crucial role in maintaining long-term 
cone function. One interesting unexplored possibility emerging 
from these results is that age-dependent decline in the efficiency 
of the Müller cell visual cycle contributes to the gradual loss of 
cone function and is linked to age-related cone visual disorders 
in patients. Thus, genetic or pharmacological treatments aimed 
at boosting the retinal visual cycle might have therapeutic benefit 
for age-dependent cone visual loss.
It has been suggested that cone dark adaptation is biphasic, 
with an initial fast recovery dominated by the retinal visual cycle 
and a slow subsequent recovery contributed by the RPE visual 
cycle (6). However, we found that the rescue of either of the 2 
visual cycles in Rlbp1–/– mice results in cone dark adaptation in vivo 
with indistinguishable kinetics (Figure 7C). It is not clear at the 
moment whether this reflects a more complex interplay between 
the contributions of the 2 visual cycles than was previously appre-
ciated, or a developmental compensatory modulation of 1 path-
way in the absence of the other. Interestingly, neither of the res-
cues of the 2 visual cycles restored the maximal cone response, 
suggesting reduced cone number or phototransduction capacity. 
One possibility is that both visual cycles are required for normal 
cone function. Alternatively, it is possible that the loss of cone 
function in Rlbp1–/– mice is caused by chromophore deficiency at 
an early stage of development and therefore could not be rescued 
by AAV injections in adult animals. While the 2 hypotheses are not 
mutually exclusive, our aging experiments on Rlbp1–/– mice (Figure 
1) support the latter. Future studies with animals of different ages 
should resolve these questions and provide invaluable informa-
tion about the therapeutic potential of such treatments. Notably, 
we were able to achieve selective and highly efficient CRALBP 
expression in Müller cells and even in the RPE (Figure 6F) with an 
intravitreal AAV injection.
Methods
Animals. CRALBP-deficient mice (22) were provided by John Saari 
(University of Washington, Seattle, Washington, USA). To facilitate 
cone recordings, CRALBP-knockout mice were crossed with rod 
transducin α–knockout mice (Gnat1–/–) (23) obtained from Janis Lem 
(Tufts University, Boston, Massachusetts, USA) to eliminate rod 
responses. The role of CRALBP in cone function and morphology was 
then determined by comparing adult (6 weeks to 6 months of age) 
control (Gnat1–/–) and Rlbp1–/– (CRALBP-deficient Gnat1–/–) mice. All 
mice used in this study were confirmed to be free of the rd8 mutation 
(48). For dark-rearing experiments, newborn mice were transferred to 
a light-proof cabinet and briefly exposed to ambient light only once 
a week during cage changing. All other mice were raised in a 60 Lux 
12-hour light/12-hour dark cycle. Animals were dark adapted for 18 
hours before electrophysiological recordings and at least 30 minutes 
prior to pupillary light reflex tests. The animals used for the optomotry 
tests were light adapted before the experiment. In addition, Rpe65–/– 
(Gnat1+/+) mice were used as control animals for pupillary light reflex 
and exogenous chromophore treatment experiments.
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microscope and an Olympus DP70 camera. Image files were anno-
tated in Adobe Photoshop with dots to mark opsin staining. The dots 
were quantified using the “Analyze Particles” feature in ImageJ soft-
ware (NIH). Quantification was conducted in 170 μm × 170 μm fields 
located in the dorsal, nasal, temporal, and ventral quadrants.
AAV vector preparation and injection. Four types of AAV vec-
tors were used for the injection: shH10-scCAG-RLBP1 (expressing 
CRALBP in Müller cells, Müller-CRALBP); 7m8-scVMD2-RLBP1 
(expressing CRALBP in RPE cells, RPE-CRALBP); shH10-scCAG-GFP 
(expressing GFP in Müller cells, GFP control); and 7m8-scVMD2-GFP 
(expressing GFP in RPE cells, GFP control). The Müller glia–specific 
viruses (shH10-scCAG-RLBP1/GFP) were constructed using a Müller 
glia–specific AAV serotype shH10 and the ubiquitous synthetic CAG 
promoter (54). The RPE-specific viruses (7m8-scVMD2-RLBP1/GFP) 
were built using a pan-retinally expressing AAV serotype 7m8 and the 
RPE-specific promoter VMD2 (55, 56). To generate the scCAG-RLBP1 
viral transfer plasmid, RLBP1 was reverse transcribed from purified 
WT mouse retina total mRNA. Then the GFP ORF of a self-comple-
mentary AAV vector expressing GFP under CAG promoter control 
was replaced with the Rlbp1 cDNA using restriction enzymes. This 
plasmid was then further processed to generate the scVMD2-RLBP1 
transfer plasmid through replacement of the CAG promoter with the 
PCR-purified VMD2 promoter. The control scCAG-GFP and scVM-
D2-GFP viral plasmids were created using the same process without 
the replacement of the GFP ORF. For the generation of each virus, 
293T cells at 80% confluence were cotransfected with the appropri-
ate transfer plasmid, pHelper plasmid, and the AAV rep/cap plasmid 
(shH10 or 7m8) at a molar ratio of 1:1:1. At 72 hours after transfection, 
cells were collected, pelleted, resuspended in lysis buffer, freeze-
thawed, and then treated with Benzonase. Cell debris was removed by 
centrifugation, and the supernatant was loaded onto an iodixanol gra-
dient and subjected to ultracentrifugation. The 40% virus–containing 
iodixanol fraction was removed from the gradient, and the iodixanol 
was replaced via buffer exchange using Amicon Ultra-15 Centrifugal 
units in PBS. Titers were determined by quantitative PCR relative to 
a standard curve (57). An aliquot of 1 to 1.5 μl of the virus was injected 
into the vitreous of anesthetized 4-week-old mice using a Hamilton 
syringe. Animals were harvested 4–5 weeks after the injection for cone 
electrophysiology experiments and 8 weeks after the injection for 
immunohistochemistry.
Pupillary light reflex. All mice were awake and manually restrained 
while a 480-nm LED light was directed to 1 eye (the left eye). The light 
stimulus lasted for 30 seconds, after which the mouse was returned to 
its cage to dark adapt until the next light stimulus. Individual frames of 
the movie were taken from VLC Media Player. The images were ana-
lyzed in ImageJ. A comparison was made of the pupil area in darkness 
and after 30 seconds of light exposure to generate a ratio. For dose- 
response curves, the data were fitted with a variable-slope sigmoidal 
dose-response curve, with the top constrained to 1.0 and the bottom 
constrained between 0 and 0.1.
Statistics. Unless otherwise noted, a 2-tailed unpaired Student’s 
t test was used to test for the significance of differences in the mean 
values of 2 sample groups. A P value of less than 0.05 was considered 
statistically significant.
Study approval. The care, maintenance, and treatment of the ani-
mals in this study followed protocols approved by the Washington 
University Animal Studies Committee.
then obtained using transretinal recordings. For all recordings, the sen-
sitivity, Sf, was estimated from the ratio of the amplitude, r, of a flash 
response from the linear range (<30% of the saturated response, rmax) 
and the corresponding flash intensity.
Frozen sections. Eyes were fixed in 4% paraformaldehyde in PBS 
for 2 hours at room temperature, rinsed with PBS, and then cryopro-
tected in 30% sucrose. The lens was removed prior to embedding 
in Tissue-Tek OCT compound (Sakura). Frozen blocks were cryo-
sectioned at a thickness of 12 to 14 μm. For immunohistochemical 
staining, sections were blocked for approximately 1 hour at room 
temperature, followed by overnight incubation at 4°C with primary 
antibody, except for anti-CRALBP, which was incubated for 2 hours 
at room temperature. The following primary antibodies were used: 
rabbit anti–red/green cone opsin (AB5405; EMD Millipore) at 1:600; 
rabbit anti–blue cone opsin (AB5407; EMD Millipore) at 1:200; and 
rabbit anti-CRALBP (UW55 polyclonal antibody isolated from rab-
bits immunized with human recombinant CRALBP; a gift of John 
Saari, University of Washington; refs. 22, 53) at 1:200. The following 
fluorescently labeled secondary antibodies were used, respectively: 
Alexa Fluor 555 donkey anti-rabbit (A-31572; Molecular Probes) at 
1:800; Alexa Fluor 488 donkey anti-rabbit (A-21206; Molecular 
Probes) at 1:500; and Alexa Fluor 555 donkey anti-rabbit (A-31572; 
Molecular Probes) at 1:800. Secondary antibodies were applied for 
30 minutes at room temperature, followed by DAPI staining, appli-
cation of VECTASHIELD (Vector Labs), and coverslipping. The 
following blocking solutions were used: 0.1% Triton X-100 and 5% 
normal donkey serum in PBS for staining of opsins, and 0.5% Triton 
X-100 and 2% normal donkey serum in PBS for staining of CRALBP. 
Primary and secondary antibodies were diluted in blocking solu-
tion. Slides were stored at –20°C until imaging. Images were taken 
as multi-plane captures using an Olympus BX61WI microscope and 
a Hamamatsu ORCA-AG CCD camera and processed with Meta-
Morph software (Molecular Devices) and Adobe Photoshop, except 
for Figure 6, E and F, which were taken as single-plane captures 
using an Olympus BX51 microscope and an Olympus DP70 camera 
and processed with SlideBook software (Intelligent Imaging Innova-
tions) and Adobe Photoshop.
Whole-mount immunostaining. Retinae were dissected in PBS 
with the lens intact, fixed for 30 minutes at room temperature with 
4% paraformaldehyde in PBS, and rinsed with PBS prior to removal of 
the lens. Retinae were blocked for approximately 1 hour at room tem-
perature, followed by overnight incubation at 4°C with the primary 
antibody. The following primary antibodies were used: rabbit anti–
red/green cone opsin (AB5405; EMD Millipore) at 1:500 and goat 
anti–blue opsin (sc-14363; Santa Cruz Biotechnology Inc.) at 1:500. 
The following fluorescently labeled secondary antibodies were used, 
respectively: Alexa Fluor 555 donkey anti-rabbit (A-21206; Molecu-
lar Probes) at 1:800 and Alexa Fluor 488 donkey anti-goat (A-11055; 
Molecular Probes) at 1:800. Secondary antibodies were applied for 
30 minutes at room temperature. A blocking solution consisting of 
0.5% Triton X-100 and 2% normal donkey serum in PBS was used. 
Primary and secondary antibodies were diluted in blocking solution. 
Retinae were stored light-protected in PBS at 4°C until imaging, 
whereupon they were whole mounted with glass shards at the cor-
ners of the slide and coverslipped.
Cone quantification. Whole-mounted retinae were imaged as sin-
gle-plane captures using a ×10 objective lens with an Olympus BX51 
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